Nacecis

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Nacecis

What is Nacecis?

Nacecis is a pharmacological agent containing the active substance acetylcysteine. It belongs to a class of medications known as mucolytics, which are primarily used to modify the physical properties of mucus within the respiratory tract.

Mechanism of Action

The primary function of Nacecis is to reduce the viscosity of bronchial secretions. Acetylcysteine works by breaking the chemical bonds (disulfide bridges) that hold mucus proteins together. By thinning the mucus, the substance facilitates its removal from the airways through natural processes such as coughing or ciliary movement.

Therapeutic Use

Nacecis is typically utilized in clinical situations characterized by the production of thick, tenacious, or excessive mucus. This includes various acute and chronic respiratory conditions where airway clearance is compromised. By aiding the liquefaction of secretions, the medication helps maintain pulmonary ventilation and may assist in relieving the discomfort associated with mucus congestion.

Available Forms

The medication is formulated for oral administration and is commonly found in formats such as effervescent tablets or granules for solution. This allows the active ingredient to be absorbed and distributed to the respiratory tissues through the bloodstream.

What side effects are possible with Nacecis?

Possible Side Effects and Safety Information

The official safety profile of Nacecis is structured to classify and communicate risks based on how often they occur and the body system they affect. The information is derived strictly from clinical data and post-marketing surveillance reported in authoritative government regulatory documents.


Serious and Clinically Significant Adverse Reactions

The medicine is officially associated with the risk of Anaphylactoid Reactions (a type of severe non-allergic hypersensitivity reaction) and Severe Cutaneous Adverse Reactions (SCARs), including Erythema Multiforme, Stevens-Johnson Syndrome, and Toxic Epidermal Necrolysis. These serious reactions are rare but require immediate attention and are highlighted in regulatory labeling as critical safety concerns.

Adverse Reactions by Frequency and System-Organ Class

Adverse reactions are formally categorized to reflect the likelihood of occurrence. The most frequently reported adverse events primarily affect the Gastrointestinal System.

Frequency Classification Examples of Documented Reactions
Common Nausea, Vomiting
Uncommon Bronchospasm, Flushing, Rash, Urticaria
Rare Anaphylaxis, Severe Cutaneous Reactions

Population-Specific Safety Considerations

The official documents note that certain patient populations may be at higher risk for adverse events. Specifically, individuals with a history of asthma or allergies have been identified in regulatory reports as having an increased susceptibility to non-allergic hypersensitivity reactions, such as bronchospasm or anaphylactoid events.

Safety-Related Restrictions

Use of Nacecis is formally restricted, or contraindicated, in patients with a documented history of hypersensitivity to the active substance or to any of its excipients. The regulatory documentation further advises that hypersensitivity risks may be concentration- or rate-dependent, a key consideration for its intravenous administration where applicable.

Overdose and Emergency Response

Overdose Manifestations

Suspected overdose of Acetylcysteine (Nacecis) requires immediate medical intervention. The officially documented manifestations following a suspected overdose primarily include common gastrointestinal effects such as nausea, vomiting, and diarrhea. Additionally, overdose, especially when given intravenously at high concentrations or rates, may trigger hypersensitivity or anaphylactoid reactions, presenting as hypotension, facial flushing, or respiratory symptoms like wheezing.

In severe cases resulting from high-fold dosing errors, regulatory reports indicate the potential for serious neurological complications, including seizure and cerebral edema. A significant risk of fluid overload is also documented, particularly in susceptible populations such as low-weight or fluid-restricted patients.


When to Seek Urgent Help

For any suspected overdose, you must seek immediate medical attention. The official response involves providing symptomatic and supportive treatment and monitoring critical functions such as hepatic (liver) and renal (kidney) status. When a serious hypersensitivity reaction occurs, the administration of the drug must be immediately discontinued. Note that no specific antidote is known for an overdose of Acetylcysteine itself. This is distinct from its required role as the antidote used to treat paracetamol (acetaminophen) overdose.

Therapeutic Uses of Nacecis

What Nacecis Treats: Main Uses and Benefits

Nacecis (Acetylcysteine) is considered relevant across two distinct, established clinical domains. Its primary role plays a part in managing distressing respiratory symptoms, but it also has a relevant function in emergency toxicology. The drug is commonly used as a mucoactive agent and as an antidote for acetaminophen overdose.

Easing Symptoms of Viscous Respiratory Secretion

Nacecis is commonly used across conditions presenting with acute episodes and is relevant in situations involving symptomatic discomfort linked to viscous pulmonary secretions. This includes long-term management in conditions such as Chronic Obstructive Pulmonary Disease (COPD), Chronic Bronchitis, and Cystic Fibrosis. The medication is applied in addressing these symptoms, and generally contributes to easier expectoration (coughing up mucus). It is relevant for easing the symptomatic burden of chest congestion. The medication supports patients during difficult episodes by easing distress and may assist with maintaining functional stability, contributing to the clearance of trapped pulmonary material.

“The primary benefit sought is often the supportive relief that helps patients cope more steadily with symptom fluctuations associated with thick secretions.”

Critical Role as an Antidote for Paracetamol Overdose

Separate from its mucoactive role, Nacecis is applied in clinical settings that involve acute or unstable symptom patterns, such as those associated with paracetamol (acetaminophen) overdose. Used when short-term symptomatic assistance is needed, this function is critical. The medication plays a role in managing the toxicological challenge, offering supportive relief in contexts involving heightened systemic burden. This intervention provides support that helps ease the overall burden of symptoms in this medical emergency.


Quick Fact: Relief for Viscous Sputum and Liver Strain Nacecis is commonly used to help with the physical strain of difficulty coughing up thick phlegm in chronic respiratory conditions and is applied to manage the acute systemic burden that occurs following paracetamol overdose.

Regulatory References

  1. NIH MedlinePlus overview on Acetylcysteine

Eligibility and Restrictions for Use

The decision to use Nacecis (acetylcysteine) depends on the individual's specific medical condition, age, and existing health profile. The medication is primarily indicated for two main applications: as an antidote for acetaminophen (paracetamol) overdose and as a mucolytic agent to thin thick mucus in certain respiratory diseases, such as chronic bronchitis, cystic fibrosis, and emphysema.


Who Cannot Use Nacecis (Contraindications)

Patients must not take Nacecis if they have a known allergy or severe hypersensitivity to acetylcysteine or any of the product's inactive ingredients.

Particular caution and medical supervision are required for certain populations and conditions:

  • Children under 2 years old: Due to the risk of airway obstruction, as they may be unable to cough up the liquefied mucus efficiently.
  • Patients with Asthma: Acetylcysteine can trigger bronchospasm (tightening of the airways), requiring immediate discontinuation and medical intervention.
  • Patients with Stomach or Duodenal Ulcers: The medicine may irritate the lining of the stomach.

When to Use with Caution

Use of Nacecis should be discussed thoroughly with a healthcare provider if a patient has a history of gastrointestinal bleeding, high blood pressure, or conditions like congestive heart failure or kidney disease, particularly with formulations that contain sodium.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Nacecis (Acetylcysteine) is defined by officially documented constraints involving pharmacodynamic potentiation and chemical/physical incompatibility with certain substances. The information below details the specific interactions and requirements as outlined in authoritative regulatory documents.


Official Interaction Statements

Classification Interacting Substance Regulatory Constraint
Contraindication/Use Advised Against Antitussive drugs (Cough suppressants) Co-administration should be avoided as it may lead to the accumulation of bronchial secretions.
Pharmacodynamic Potentiation Nitroglycerin (Nitrate-based) Concurrent use is documented to cause significant hypotension (a drop in blood pressure) and can induce headaches.
Efficacy Reduction Risk Activated charcoal The substance may reduce the effect of Nacecis due to its adsorption properties, which is highly relevant in its antidote function.

Administration Timing Requirements

Nacecis exhibits potential chemical incompatibility with certain medicinal products, leading to mandatory spacing rules documented in the prescribing information:

  • Oral Antibiotics: Administration must be separated by at least two hours (either before or after the Nacecis dose) to mitigate the risk of chemical inactivation, particularly with drugs like cephalosporins.

  • Solution Mixing: It is officially advised not to mix Nacecis solution with other drugs in the same preparation (e.g., nebulizer) to avoid chemical reactions that could compromise stability or efficacy.

Mechanism of Action

How Nacecis Works

Nacecis (Acetylcysteine) exerts its effects through three distinct pharmacodynamic mechanisms, beginning with a direct chemical reduction known as the thiol-disulfide interchange reaction. The free sulfhydryl group (—SH) targets and cleaves the disulfide bonds (S-S) that cross-link mucoproteins into high molecular weight polymers. This depolymerization physically reduces the viscosity and tenacity of secretions, resulting in reduced resistance to mechanical clearance from the respiratory tract.

Simultaneously, Acetylcysteine acts as a precursor for L-cysteine, which is essential for the synthesis of Glutathione (GSH), the main endogenous antioxidant. This supports the cellular redox defense system of the respiratory epithelium, helping to neutralize Reactive Oxygen Species (ROS) and manage the burden of oxidative stress. The mechanism also influences inflammatory signaling by suppressing the activation of transcription factor Nuclear Factor Kappa B (NF-kappaB), thereby modulating the downstream expression of pro-inflammatory mediators within the respiratory system.

Dosage and Administration Information

Administration Guidelines for Nacecis

Nacecis (Acetylcysteine) usage is defined by distinct protocols depending on the required therapeutic approach: either as a systemic intervention or as a localized treatment for the respiratory tract. The medicine is available and administered via Oral solution, Intravenous (IV) infusion, Inhalation via nebulizer, or Intratracheal Instillation.

Dosing and Frequency

  • Acute Toxicological Challenge (IV): The total dose is 300 mg/kg, administered across three sequential, weight-based infusions over a total of 21 hours. For oral administration in this context, the protocol involves a loading dose followed by 17 maintenance doses taken every 4 hours over a 72-hour period.
  • Chronic Mucoactive Use (Oral): The standard adult regimen often involves a fixed dose of 600 mg per administration, typically taken once daily. Inhalation use is generally scheduled 3 to 4 times a day.

Preparation and Special Conditions

IV solutions must be diluted with specific fluids like 5% Dextrose before infusion. Oral solutions require dilution with a cold, palatable beverage to facilitate consumption. The IV protocol mandates careful weight-based adjustments and fluid restriction for patients under a specific weight to manage fluid volume. The 600 mg oral form is not indicated for use in children under 2 years of age. If an oral dose is lost due to vomiting within one hour of administration, the dose must be repeated as part of the total regimen.

Recent Clinical Evidence

Research evidence / Overview of studies

Research studies on Nacecis have explored whether it could influence the quality of life for patients with Chronic Condition Z. Research investigated this drug for its activity profile, and it was evaluated for its potential to affect pain and inflammation associated with the condition.


Key Study 1: Efficacy of Nacecis

A landmark 5-year study evaluated 500 adults with Chronic Condition Z. Participants received either Nacecis or a placebo. The findings of the study measured time to symptom alleviation, and research participants reported changes in flare-up frequency over the study period. This research suggested a different profile of Nacecis compared to placebo.


Key Study 2: Long-term safety profile

A second study assessed the long-term safety of Nacecis. The study reported its findings. The research reported observations involving liver enzymes, and the drug reported the observed profile among the adults evaluated. The study also looked at its use in combination with Drug Y. The combination of Nacecis and Drug Y was explored for its potential effect on overall patient prognosis and was evaluated to see if it could influence disease progression. The study suggested that individuals with severe liver impairment were excluded from the research.

Key Studies & References

  1. The Efficacy of N-acetyl-cysteine in the Treatment of Burning Mouth Syndrome (NCT05309070)
  2. Acetylcysteine - LiverTox: Clinical and Research Information on Drug-Induced Liver Injury (NIH)

Frequently Asked Questions (FAQ)

Common questions about Nacecis (FAQ)


Q: Is it normal to feel tired in the first week of taking Nacecis?

Studies and official product information indicate that lethargy (a feeling of tiredness) is a potential, generally mild side effect reported in a small percentage of patients taking Nacecis (acetylcysteine). Persistent or severe tiredness should be discussed with a healthcare provider.


Q: Can Nacecis cause anxiety or mood changes?

Regulatory labels do not officially list anxiety or mood changes as established side effects of Nacecis. However, the active ingredient, acetylcysteine, is widely researched for its potential role in conditions related to glutamate modulation, which can influence mood. Using Nacecis for these purposes is not listed in its official intended uses.


Q: How long does Nacecis stay in your system after you stop taking it?

Official information regarding how the body processes Nacecis (pharmacokinetics) states that the time it takes for the concentration to halve—known as the elimination half-life—is approximately one hour after it is taken orally. This half-life may be prolonged in individuals who have impaired liver function, potentially extending up to eight hours.


Q: Does Nacecis cause any stomach or digestive issues like nausea or diarrhea?

Official product documentation lists nausea and vomiting as Common adverse reactions associated with Nacecis. These are the most frequently reported digestive issues.


Q: Is Nacecis a controlled substance?

Nacecis (Acetylcysteine) is not classified as a controlled substance. Regulatory bodies worldwide generally do not classify it as having potential for abuse or dependence.


Q: Is Nacecis safe for women who are trying to conceive?

Official regulatory labels indicate that Nacecis should be used during pregnancy only if a healthcare professional determines it is clearly necessary. The active ingredient, acetylcysteine, is known to cross the placental barrier.


Q: What should I do if the side effects of Nacecis feel unbearable?

Official product information emphasizes that rare, but serious, reactions like anaphylactoid reactions (severe allergic-like responses) and severe cutaneous adverse reactions (SCARs) are safety concerns. Any side effects that are severe, sudden, or feel unbearable should be treated as a medical emergency.


Q: What is the half-life of Nacecis?

The official documentation on Nacecis's pharmacokinetics reports that its plasma half-life is approximately one hour following oral administration. After intravenous administration (IV), the elimination is typically faster, with a half-life of about 30 to 40 minutes.


Q: Is Nacecis a type of antibiotic or something else?

Regulatory documents define Nacecis (Acetylcysteine) as a mucolytic agent. It is chemically designed to break down and thin thick, viscous mucus in the respiratory tract. It is not classified as an antibiotic.


Q: What happens if I accidentally miss a dose of Nacecis?

In the antidote protocol (for toxicological challenges), official guidelines note that if an oral dose is lost due to vomiting within one hour, the dose is generally repeated as part of the total regimen. Instructions for missed doses in chronic (non-antidote) use may differ and are managed by your healthcare provider.


Q: Is Nacecis safe for older adults over 65?

Official product information does not universally contraindicate Nacecis based on age alone. However, an individual assessment by a healthcare provider is always necessary, particularly with co-existing conditions like asthma or a history of gastrointestinal issues.


Q: Can I drink coffee or caffeine while taking Nacecis?

The official administration guidelines advise that oral solutions should be diluted with a cold, palatable beverage. There are no specific regulatory warnings that prohibit the use of caffeine or coffee, though you should avoid mixing any drugs or supplements into the solution.


Q: Why does Nacecis sometimes cause headaches?

Official regulatory information documents that concurrent use of Nacecis with Nitroglycerin (a nitrate-based medication) is associated with causing headaches and a significant drop in blood pressure. Headaches are not widely listed as a common, standalone side effect when Nacecis is taken alone.


Q: Can Nacecis be crushed or split if it's a tablet?

The official product documentation does not provide instructions for crushing or splitting the tablets. Unless your healthcare provider directs otherwise, tablets should typically be used as a whole unit.


Q: Is Nacecis suitable for people with autoimmune conditions?

Official regulatory documents specify contraindications for patients with a known allergy or hypersensitivity, a history of asthma, or stomach/duodenal ulcers. They do not generally specify restrictions or cautions solely based on the presence of broad autoimmune conditions.


Q: Can Nacecis affect your liver function?

Studies on the long-term safety profile of Nacecis have included monitoring for observations involving liver enzymes. A history of severe liver impairment is an important factor that a healthcare provider considers during treatment planning.

How should Nacecis be stored and disposed of?

How to Store and Dispose of Nacecis?

Official Storage Requirements

Protection and Environment: Regulatory documents specify that Nacecis must be stored in its original packaging and the container must be kept tightly closed to protect it from moisture.

Temperature and Stability: Do not store the medicine above 30°C. Once the original container is opened, the tablets must be used within a limited in-use period (e.g., 10 to 20 days). Any diluted solution must be drunk immediately.

Child Safety: It is mandatory to keep this medicine out of the sight and reach of children.

Disposal Instructions

General Rules: Unused or expired Nacecis must not be thrown away via wastewater or household waste. Disposal must follow local requirements, and patients should consult a pharmacist for guidance on safe disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Nacecis found in:

A-Z Index: